Message from the Chair, Italy
Greetings from Italy!
This is the first Newsletter of the year 2022 and the first that is written by Italy as a Chair of the GHSA Steering Group. Yet the activity for 2022 has already started with a good pace.
2022 GHSA Ministerial Meeting in Seoul
Dr. Fauci was appointed Director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis and malaria as well as emerging diseases such as Ebola and Zika. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. The NIAID budget for fiscal year 2022 is approximately $6.3 billion.
Dr. Fauci has advised seven Presidents on HIV/AIDS and many other domestic and global health issues. He was one of the principal architects of the President’s Emergency Plan for AIDS Relief (PEPFAR), a program that has saved millions of lives throughout the developing world.
We’ll tell you the best ways to allocate money across stocks and bonds, and how you should invest
You’ll get expert and specialist data and evaluation to help you build strong mutual trust plans.
You’ll no longer have to worry about managing your pensions or IRAs anymore because we’ll take care of it.
Retiring soon? We’ll help you plan out your entire future so that you can relax and spend your days with fun!
2022 GHSA Ministerial Meeting in Seoul
Greetings from Italy!
This is the first Newsletter of the year 2022 and the first that is written by Italy as a Chair of the GHSA Steering Group. Yet the activity for 2022 has already started with a good pace.
Dear all GHSA Colleagues,
Sawasdee from Thailand!
It was a pleasure serving as the Chair of the Global Health Security Agenda Steering Group this past year.
The Africa Centres for Disease Control and Prevention and the Government of Uganda will assume responsibilities as co-Chair of the GHSA Action Package for Biosafety and Biosecurity (APP3) for the 2021-2022 term beginning in November of this year.
We have now reached the midway point of the year and the midway point in our role as the GHSA Steering Group Chair. While some countries are showing signs of optimism that we can emerge from COVID-19, the state of the world is still that of a pandemic.